Microbot Medical Inc. Increases CFO Salary

What Happened

• Microbot Medical Inc. filed a Form 8‑K (Item 5.02) reporting an amendment to the employment agreement of its Chief Financial Officer, Rachel Vaknin. On August 6, 2026 the company executed Addendum #4 to increase Ms. Vaknin’s annual base salary to NIS 864,000 (stated as the equivalent of $288,000 using a 3:1 NIS-to-USD rate), effective August 1, 2026. The addendum is included as Exhibit 10.1 to the filing.

Key Details

• Effective date of salary increase: August 1, 2026.
• New annual base salary: NIS 864,000 (equivalent stated as $288,000 at a 3:1 exchange rate).
• Action documented: Addendum #4 to Employment Agreement signed August 6, 2026 and disclosed on Form 8‑K (filed August 7, 2026).
• No other changes to role, departures, or additional compensation terms were disclosed in the filing.

Why It Matters

• This is a change in executive compensation for the company’s CFO and may modestly affect Microbot’s future general and administrative expenses. For investors, it’s a routine disclosure about management pay; the filing does not report any operational results, mergers, or departures. Monitor future filings for any additional compensation, equity grants, or broader executive changes that could have larger financial impact.